Hoth Therapeutics Announces FDA Acceptance of IND Application for HT-001 for the Treatment of Cancer Disorders Associated with Epidermal Growth Factor Receptor (EGFR) Inhibitor Therapy
On-monitor to initiate Phase 2 demo in Q1 2023 NEW YORK, Dec. 29, 2022 /PRNewswire/ — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a affected individual-focused biopharmaceutical company, these days announced that the…
X Factor star Sharon Osbourne shares health update after being rushed to hospital
Sharon Osbourne has shared a health update with her fans after being taken to the hospital last week. The presenter and former X Factor judge was taken ill on the…
Defendents’ access to medical treatment in jail not a factor in bail decisions, NH Supreme Court rules
Judges in New Hampshire are not permitted to take into consideration whether denying bail to a defendant with health-related circumstances jeopardizes their protection though incarcerated, according to an unanimous viewpoint…







